There is an error in Fig 2, “Structural features observed by electron microscope (10000× and 5000×) in PC3, DU145, and LNCaP prostate cancer cells treated with KML001 for 24 and 48 h.” Please see the correct Fig 2 here.
thumbnail
Download:
*
PPT
PowerPoint slide
*
PNG
larger image
*
TIFF
original image
Fig 2. Structural features observed by electron microscope (10000× and 5000×) in PC3, DU145, and LNCaP prostate cancer cells treated with KML001 for 24 and 48 h.
https://doi.org/10.1371/journal.pone.0225087.g001
There is an error in Fig 3, “Induction of apoptosis by KML001 in prostate cancer cells.” Please see the correct Fig 3 here.
thumbnail
Download:
*
PPT
PowerPoint slide
*
PNG
larger image
*
TIFF
original image
Fig 3. Induction of apoptosis by KML001 in prostate cancer cells.
(A) FACS analysis of annexin V/PI staining. Results show early apoptosis, defined as annexin V-positive and PI-negative cells, and late apoptosis, defined as annexin V-positive and PI-positive cells. Results were expressed as means ± SD of three independent experiments. (B) Western blot analysis of the time- and dose-dependent cleavage of PARP and activation of procaspase-3.
https://doi.org/10.1371/journal.pone.0225087.g002
There is an error in Fig 4, “Induction of autophagy by KML001 in prostate cancer cells.” Please see the correct Fig 4 here.
thumbnail
Download:
*
PPT
PowerPoint slide
*
PNG
larger image
*
TIFF
original image
Fig 4. Induction of autophagy by KML001 in prostate cancer cells.
(A) Western blot analysis of the time- and dose-dependent conversion of LC3-I to-II. (B) Inhibition by 3-MA of KML001-induced conversion of LC3 in prostate cancer cells. (C) Cells were exposed to 10 μM (PC3), 5 μM (DU145), or 2 μM (LNCaP) KML001 in the presence or absence of 1 mM 3-MA for 72 h. Results were expressed as means ± SD of three independent experiments. * p < 0.05 by one-way ANOVA.
https://doi.org/10.1371/journal.pone.0225087.g003
There is an error in Fig 5, “Regulation of autophagy and apoptosis by ROS.” Please see the correct Fig 5 here.
thumbnail
Download:
*
PPT
PowerPoint slide
*
PNG
larger image
*
TIFF
original image
Fig 5. Regulation of autophagy and apoptosis by ROS.
All 3 prostate cancer cells were treated with the indicated concentration of KML001 in the absence or presence of 5 mM NAC for 24 h. (A) KML001 induces dose-dependent ROS (blue) accumulation. Cells were stained with DCFH-DA and washed with PBS. More than three fields in each cell were observed by fluorescence microscope (200×), and representative images are shown. (B) NAC inhibition of KML001-induced conversion of LC and caspase activation in prostate cancer cells. (C) Cells were exposed to 10 μM (PC3), 5 μM (DU145), or 2 μM (LNCaP) KML001 in the presence or absence of 1 mM NAC for 72 h. Results were expressed as means ± SD of three independent experiments. * p < 0.05 by one-way ANOVA.
https://doi.org/10.1371/journal.pone.0225087.g004
1. You D, Kim Y, Jang MJ, Lee C, Jeong IG, Cho YM, et al. (2015) KML001 Induces Apoptosis and Autophagic Cell Death in Prostate Cancer Cells via Oxidative Stress Pathway. PLoS ONE 10(9): e0137589. https://doi.org/10.1371/journal.pone.0137589 pmid:26352139
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2019 You et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Abstract
There is an error in Fig 2, “Structural features observed by electron microscope (10000× and 5000×) in PC3, DU145, and LNCaP prostate cancer cells treated with KML001 for 24 and 48 h.” Please see the correct Fig 2 here. thumbnail Download: * PPT PowerPoint slide * PNG larger image * TIFF original image Fig 2. Structural features observed by electron microscope (10000× and 5000×) in PC3, DU145, and LNCaP prostate cancer cells treated with KML001 for 24 and 48 h. https://doi.org/10.1371/journal.pone.0225087.g001 There is an error in Fig 3, “Induction of apoptosis by KML001 in prostate cancer cells.” (B) Western blot analysis of the time- and dose-dependent cleavage of PARP and activation of procaspase-3. https://doi.org/10.1371/journal.pone.0225087.g002 There is an error in Fig 4, “Induction of autophagy by KML001 in prostate cancer cells.”
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer